Time in-range blood glucose level (70-140 mg/dl) is one of the greatest challenges when managing diabetes. Digital engagement can play a pivotal role in the care of patients with diabetes and other chronical conditions, potentially improving patient’s compliance. In this study DarioTM Blood Glucose Monitoring System (BGMS) users were evaluated to examine whether higher App engagement contributes to better diabetes management.

Method: A retrospective data evaluation study was performed on the DarioTM cloud database. A population of active type 2 diabetic (T2D) users (>15 measurements per month on average) was evaluated. The study assessed the ratio of in-range blood glucose readings (70-140 mg/dL) as a function of App engagement level for 6 months as recorded in the database compared to first 30 days as a starting point of analysis.

Results: A population of 4917 T2D non-insulin users measuring more than 15 times per month on average during 6 months in a row was evaluated. The ratio of in-range (70-140 mg/dL) readings was increased following 3 months in correlation to the level of tagging meal reference/carbs/physical activity occurrences (4.0%, 9.1% and 11.9% for tagging 0-1, 1-2 and >2 times per day on average, respectively) and sustained for 6 months (3.1%, 7.0% and 12.2%, respectively). In subgroup analysis focusing on users entering their meal reference, high correlation was observed following 3 months with an increase of in-range measurements in 4.6%, 8.4% and 12.0% for 0-1, 1-2 and >2 meal reference tagging per day on average, respectively, and maintained stability over 6 months period (3.2%, 7.4%, and 12.5%, respectively).

Conclusion: The combination of a glucose meter, an App and engaged user may promote better behavioral modification which enhance and sustain adherence to diabetes management.


Y. Hershcovitz: Employee; Self; DarioHealth. S. Dar: Employee; Self; DarioHealth. E. Feniger: Employee; Self; DarioHealth.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.